As ZNF545 was downregulated in breast cancer with ER+, PR+ and HER2-, compared with paired adjacent non-tumor tissues, ZNF545 may function as a candidate tumor suppressor in Luminal A subtype breast cancer. Here, ESR1 is linked to neoplasm.